Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people - The WATCH study
- PMID: 25805711
- PMCID: PMC4442716
- DOI: 10.1016/j.diabres.2015.03.001
Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people - The WATCH study
Abstract
Aims: Previously rare among Alaska Native (AN) people, type 2 diabetes (DM2) prevalence as indicated by registry data has increased by as much as 300% in some western Alaska regions. We sought to determine prevalence and incidence of DM2 and analyze associated cardiometabolic risk factors in western AN people.
Methods: DM2 and prediabetes prevalence and incidence were determined by the Western Alaska Tribal Collaborative for Health using consolidated data from cohort studies conducted during 2000-2010. Crude and age-adjusted incidence for DM2 and prediabetes were calculated using 2010 American Diabetes Association criteria. Effects of covariates on DM2 and prediabetes were determined using univariate and multivariate Cox proportional hazards analyses, adjusted for age and sex.
Results: Excluding baseline diabetes (n=124, 4.5%), 53 cases of new DM2 were identified among 2630 participants. Age- and sex-adjusted DM2 incidence was 4.3/1000 (95% CI 2.9, 5.0) person-years over an average 5.9-year follow up. After excluding baseline prediabetes, 387 new cases of prediabetes were identified among 1841 participants; adjusted prediabetes incidence was 44.5/1000 (95% CI 39.5, 49.5) person years. Independent predictors for DM2 included age, impaired fasting glucose, and metabolic syndrome; family history of diabetes and obesity were additional independent predictors for prediabetes.
Conclusions: DM2 incidence in western AN people is substantially lower than that for U.S. whites; however, incidence of prediabetes is more than 10-fold higher than western AN DM2 incidence and more closely aligned with U.S. rates. Interventions aimed at achieving healthy lifestyles are needed to minimize risk factors and maximize protective factors for DM2 in this population.
Keywords: Alaska Native (AN); DM2; Metabolic syndrome; Prediabetes; Risk factors; Western Alaska Tribal Collaborative for Health.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
Figures
References
-
- Parran T, Ciocco A, Crabtree JA, McNerny WJ, McGibony JR, Wishik SM, Elder MQ. Alaska’s health: A survey report to the United States Department of the Interior. Pittsburgh, PA: Graduate School of Public Health, University of Pittsburgh; 1954.
-
- Narayanan ML, Schraer CD, Bulkow LR, Koller KR, Asay E, Mayer AM, Raymer TW. Diabetes prevalence, incidence, complications and mortality among Alaska Native people, 1985–2006. Int J Circumpolar Health. 2006;69:236–252. - PubMed
-
- Carter EA, MacCleur JW, Dyke B, Howard BV, Devereux RB, Ebbesson SO, Resnick HE. Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Diabetologia. 2006;49:29–35. - PubMed
-
- Lanier AP, Day G, Asay E, Redwood D. Report to Yukon Kuskokwim Health Corporation Prospective Study of Alaska Natives and American Indians EARTH (Education and Research Toward Health) Research Project. Anchorage, AK: Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium; 2008.
-
- Mohatt GV, Plaetke R, Klejke J, Luick B, Lardon C, Bersamin A, Hopkins S, Dondanville M, Herron J, Boyer B Center for Alaska Native Health Research. The Center for Alaska Native Health Research study: A community-based participatory research study of obesity and chronic disease-related protective and risk factors. Int J Circumpolar Health. 2007;66:8–18. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA096095/CA/NCI NIH HHS/United States
- U01 HL064244/HL/NHLBI NIH HHS/United States
- DK097307/DK/NIDDK NIH HHS/United States
- U01 HL64244/HL/NHLBI NIH HHS/United States
- P20 RR016430/RR/NCRR NIH HHS/United States
- 1K23DK091363-03/DK/NIDDK NIH HHS/United States
- UL1 RR031975/RR/NCRR NIH HHS/United States
- R01 CA088958/CA/NCI NIH HHS/United States
- CA96095/CA/NCI NIH HHS/United States
- UL1RR031975/RR/NCRR NIH HHS/United States
- P20 RR16430/RR/NCRR NIH HHS/United States
- K23 DK097307/DK/NIDDK NIH HHS/United States
- P30GM103325/GM/NIGMS NIH HHS/United States
- R21DK44592/DK/NIDDK NIH HHS/United States
- C06 RR030495/RR/NCRR NIH HHS/United States
- P30 GM103325/GM/NIGMS NIH HHS/United States
- CA88958/CA/NCI NIH HHS/United States
- R01 DK074842/DK/NIDDK NIH HHS/United States
- K23 DK091363/DK/NIDDK NIH HHS/United States
- F33 DK009919/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical